Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$1.59B |
| 2 |
TotalEnergies
TTE
|
+$1.27B |
| 3 |
Warner Bros
WBD
|
+$838M |
| 4 |
Vanguard S&P 500 ETF
VOO
|
+$782M |
| 5 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$707M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TC Energy
TRP
|
+$2.77B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$2.27B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.1B |
| 4 |
Meta Platforms (Facebook)
META
|
+$1.6B |
| 5 |
Microsoft
MSFT
|
+$1.58B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.21% |
| 2 | Financials | 9.57% |
| 3 | Consumer Discretionary | 8.08% |
| 4 | Healthcare | 7.31% |
| 5 | Communication Services | 6.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3326
PUT
SLB Ltd
SLB
$75B
| $7.68M | ﹤0.01% |
200,000
-50,000
| -20% | -$1.81M |
|
3327
BW LPG
BWLP
$3.3B
| $7.66M | ﹤0.01% |
584,764
-270,310
| -32% | -$3.45M |
|
3328
CALL
Comstock Resources
CRK
$3.94B
| $7.65M | ﹤0.01% |
330,000
+301,100
| +1,042% | +$6.64M |
|
3329
Ginkgo Bioworks
DNA
$521M
| $7.64M | ﹤0.01% |
919,309
+94,021
| +11% | +$1.01M |
|
3330
PUT
United Airlines
UAL
$42.1B
| $7.64M | ﹤0.01% |
68,300
-550,000
| -89% | -$55.6M |
|
|
ECO
3331
Okeanis Eco Tankers
ECO
$2.42B
| $7.63M | ﹤0.01% |
225,358
+42,414
| +23% | +$1.44M |
|
|
GBND
3332
Goldman Sachs Core Bond ETF
GBND
$523M
| $7.62M | ﹤0.01% |
150,000
-125,000
| -45% | -$6.38M |
|
3333
Ero Copper
ERO
$3.58B
| $7.61M | ﹤0.01% |
269,112
-565,737
| -68% | -$13.2M |
|
3334
First Trust Capital Strength ETF
FTCS
$7.95B
| $7.61M | ﹤0.01% |
82,265
+3,179
| +4% | +$294K |
|
3335
Wolfspeed
WOLF
$1.71B
| $7.59M | ﹤0.01% |
435,917
+377,431
| +645% | +$8.66M |
|
3336
PUT
Norwegian Cruise Line
NCLH
$8.84B
| $7.58M | ﹤0.01% |
339,700
-353,600
| -51% | -$7.47M |
|
3337
Akebia Therapeutics
AKBA
$252M
| $7.58M | ﹤0.01% |
4,706,437
+2,938,624
| +166% | +$6.15M |
|
3338
Albany International
AIN
$1.78B
| $7.58M | ﹤0.01% |
149,430
+54,342
| +57% | +$2.81M |
|
3339
F&G Annuities & Life
FG
$3.62B
| $7.58M | ﹤0.01% |
245,566
+156,437
| +176% | +$4.89M |
|
|
VTYX
3340
DELISTED
Ventyx Biosciences
VTYX
| $7.56M | ﹤0.01% |
837,602
+430,691
| +106% | +$3.22M |
|
3341
Harmonic Inc
HLIT
$1.28B
| $7.56M | ﹤0.01% |
764,732
-163,317
| -18% | -$1.65M |
|
3342
Flywire
FLYW
$2.16B
| $7.56M | ﹤0.01% |
533,593
-269,061
| -34% | -$3.68M |
|
3343
Opko Health
OPK
$1.02B
| $7.54M | ﹤0.01% |
5,986,913
+3,600,378
| +151% | +$5.01M |
|
3344
Nu Skin
NUS
$267M
| $7.54M | ﹤0.01% |
783,593
-5,980
| -0.8% | -$61.9K |
|
|
IAUX
3345
i-80 Gold Corp
IAUX
$1.4B
| $7.54M | ﹤0.01% |
5,161,339
+2,105,235
| +69% | +$2.39M |
|
3346
Fractyl Health
GUTS
$111M
| $7.54M | ﹤0.01% |
3,425,197
+2,934,749
| +598% | +$4.72M |
|
|
LPBB
3347
Launch Two Acquisition Corp
LPBB
$310M
| $7.5M | ﹤0.01% |
716,018
| – | – |
|
|
AXON
3348
PUT
Axon Enterprise
AXON
$46.4B
| $7.5M | ﹤0.01% |
13,200
+10,000
| +313% | +$6.21M |
|
3349
CALL
State Street SPDR S&P Biotech ETF
XBI
$10.3B
| $7.49M | ﹤0.01% |
61,400
-30,000
| -33% | -$3.44M |
|
3350
PUT
Accenture
ACN
$108B
| $7.49M | ﹤0.01% |
27,900
-42,000
| -60% | -$10.7M |
|
Similar funds
Goldman Sachs's Q4 2025 Portfolio in Review
As of Q4 2025, Goldman Sachs held 6,954 positions worth $815B, down 0.25% from $817B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Goldman Sachs's Q4 2025 filing shows 640 new, 3,023 increased, 2,153 reduced and 543 closed positions. Its largest new stake was SunocoCorp LLC: 2,575,806 shares worth $127M. The largest sale was TC Energy, an estimated $2.77B.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 21% a quarter earlier, followed by Financials and Consumer Discretionary.
- Goldman Sachs's largest Q4 2025 buy was SunocoCorp LLC: 2,575,806 shares worth $127M.
- Goldman Sachs added most to State Street SPDR Dow Jones Industrial Average ETF Trust in Q4 2025, an estimated $1.59B increase.
- Goldman Sachs's biggest Q4 2025 reduction was TC Energy, cutting an estimated $2.77B.
- Goldman Sachs fully exited Verona Pharma in Q4 2025, selling an estimated $207M.
- Goldman Sachs's ten largest holdings make up 22% of its $815B portfolio in Q4 2025.
- Goldman Sachs opened 640 new positions and closed 543 in Q4 2025.
- Goldman Sachs's portfolio value fell 0.25% quarter-over-quarter to $815B.
Based on Goldman Sachs's 13F filing for Q4 2025, filed 10 Feb 2026.